Viral vectors for dendritic cell-based immunotherapy
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (2) , 102-107
- https://doi.org/10.1016/s1471-4906(00)01813-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Efficient Expression of the Tumor-Associated Antigen MAGE-3 in Human Dendritic Cells, Using an Avian Influenza Virus VectorHuman Gene Therapy, 2000
- Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cellsGene Therapy, 2000
- Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC functionGene Therapy, 2000
- Viral Subversion of the Immune SystemAnnual Review of Immunology, 2000
- The role of B7 costimulation in T‐cell immunityImmunology & Cell Biology, 1999
- From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunitySeminars in Cell & Developmental Biology, 1998
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998
- Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 1997
- Efficient Retrovirus-Mediated Gene Transfer of Dendritic Cells Generated from CD34+Cord Blood Cells under Serum-Free ConditionsHuman Gene Therapy, 1997
- Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.The Journal of Experimental Medicine, 1976